Elevance Health Inc. (ELV)
ELV Valuation Metrics
ELV Stock Price Metrics
Last Close Price$424.431-Day Change+1.50%Market Cap (USD)$92.170B7D Return9.10%30D Return12.26%YTD Return19.81%52-Week High$426.6652-Week High Date06/09/2026Current vs High(0.52%)52-Week Low$273.7152-Week Low Date08/01/2025Current vs Low55.07%Avg Volume 1M-Beta0.68Fair Value Price$1104.64Margin of Safety160.26%
ELV Dividend Metrics
Dividend Yield1.61%Avg Yield TTM1.61%Avg Yield 3Y1.51%CAGR TTM4.91%CAGR 3Y10.13%CAGR 5Y12.48%Payout Ratio27.20%Payout Avg 3Y25.25%Payout Avg 5Y22.90%FCF Payout Ratio23.56%FCF Payout Avg 3Y33.85%FCF Payout Avg 5Y26.73%Forward YOC 3Y2.44%Forward YOC 5Y3.22%Forward YOC 10Y6.42%Ex-Date06/10/2026Payment Date06/25/2026Consec. Yearly Increases14
ELV Growth Rate Metrics
Price CAGR TTM8.94%Price CAGR 3Y(3.35%)Price CAGR 5Y1.92%Total Return CAGR TTM11.28%Total Return CAGR 3Y(1.89%)Total Return CAGR 5Y3.31%Revenue CAGR TTM9.45%Revenue CAGR 3Y7.64%Revenue CAGR 5Y9.97%Net Income CAGR TTM(11.40%)Net Income CAGR 3Y(4.89%)Net Income CAGR 5Y2.15%EPS CAGR TTM(2.44%)EPS CAGR 3Y0.83%EPS CAGR 5Y6.67%FCF CAGR TTM75.63%FCF CAGR 3Y(16.62%)FCF CAGR 5Y(7.76%)Dividends CAGR TTM4.91%Dividends CAGR 3Y10.13%Dividends CAGR 5Y12.48%
ELV Discounted Cash Flow Metrics
| Fair Value Price | $1104.64 |
| Margin of Safety | 160.26% |
ELV Revenue Metrics
ELV PE Ratio Metrics
| PE Ratio | 18.05 |
| PE Ratio Avg TTM | 13.84 |
| PE Ratio Avg 3Y | 16.38 |
| Current VS TTM Avg | +30.46% |
| Current VS 3Y Avg | +10.20% |
| Current VS 5Y Avg | +1.61% |
ELV PS Ratio Metrics
| PS Ratio | 0.47 |
| PS Ratio Avg TTM | 0.39 |
| PS Ratio Avg 3Y | 0.55 |
| Current VS TTM Avg | +20.59% |
| Current VS 3Y Avg | -15.22% |
| Current VS 5Y Avg | -27.06% |
ELV PB Ratio Metrics
| PB Ratio | 2.13 |
| PB Ratio Avg TTM | 1.73 |
| PB Ratio Avg 3Y | 2.37 |
| Current VS TTM Avg | +23.36% |
| Current VS 3Y Avg | -10.27% |
| Current VS 5Y Avg | -20.25% |
ELV Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 14.50 |
| PFCF Ratio Avg TTM | 18.05 |
| PFCF Ratio Avg 3Y | 41.27 |
| Current VS TTM Avg | -19.66% |
| Current VS 3Y Avg | -64.86% |
| Current VS 5Y Avg | -51.96% |
ELV Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.76 |
| Debt/Equity Ratio Avg TTM | 0.78 |
| Debt/Equity Ratio Avg 3Y | 0.74 |
| Current VS TTM Avg | -1.94% |
| Current VS 3Y Avg | +3.40% |
| Current VS 5Y Avg | +6.29% |
ELV PEG Ratio Metrics
| PEG Ratio | 8.48 |
| PEG Ratio Avg TTM | 8.48 |
| PEG Ratio Avg 3Y | 8.48 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
ELV FCF Yield
| FCF Yield | 6.90% |
| FCF Yield Avg TTM | 5.88% |
| FCF Yield Avg 3Y | 5.05% |
| Current VS TTM Avg | +17.41% |
| Current VS 3Y Avg | +36.73% |
| Current VS 5Y Avg | +13.69% |
ELV Earnings Yield
| Earnings Yield | 5.54% |
| Earnings Yield Avg TTM | 7.31% |
| Earnings Yield Avg 3Y | 6.27% |
| Current VS TTM Avg | -24.19% |
| Current VS 3Y Avg | -11.60% |
| Current VS 5Y Avg | -4.21% |
ELV EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 15.16 |
| Ev/Ebit Ratio Avg TTM | 11.84 |
| Ev/Ebit Ratio Avg 3Y | 13.42 |
| Current VS TTM Avg | +28.08% |
| Current VS 3Y Avg | +12.99% |
| Current VS 5Y Avg | +5.13% |
ELV EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 12.98 |
| Ev/Ebitda Ratio Avg TTM | 10.04 |
| Ev/Ebitda Ratio Avg 3Y | 11.31 |
| Current VS TTM Avg | +29.28% |
| Current VS 3Y Avg | +14.78% |
| Current VS 5Y Avg | +6.16% |
ELV EV/Assets Ratio Metrics
| Ev/Assets Ratio | 0.92 |
| Ev/Assets Ratio Avg TTM | 0.80 |
| Ev/Assets Ratio Avg 3Y | 1.03 |
| Current VS TTM Avg | +14.68% |
| Current VS 3Y Avg | -10.41% |
| Current VS 5Y Avg | -18.93% |
ELV EV/Sales Ratio Metrics
| Ev/Sales Ratio | 0.58 |
| Ev/Sales Ratio Avg TTM | 0.51 |
| Ev/Sales Ratio Avg 3Y | 0.67 |
| Current VS TTM Avg | +14.45% |
| Current VS 3Y Avg | -13.21% |
| Current VS 5Y Avg | -24.12% |
ELV Current Ratio Metrics
| Current Ratio | 1.24 |
| Current Ratio Avg TTM | 1.17 |
| Current Ratio Avg 3Y | 1.08 |
| Current VS TTM Avg | +5.98% |
| Current VS 3Y Avg | +14.29% |
| Current VS 5Y Avg | +15.89% |
ELV Quick Ratio Metrics
| Quick Ratio | 1.24 |
| Quick Ratio Avg TTM | 1.17 |
| Quick Ratio Avg 3Y | 1.08 |
| Current VS TTM Avg | +5.98% |
| Current VS 3Y Avg | +14.29% |
| Current VS 5Y Avg | +15.89% |
ELV ROIC Metrics
| ROIC | 6.65% |
| ROIC Avg 3Y | 7.11% |
| ROIC Avg 5Y | 7.33% |
| Current VS 3Y Avg | -6.44% |
| Current VS 5Y Avg | -9.28% |
| Current VS 10Y Avg | -4.23% |
ELV Return on Assets Metrics
| ROA | 4.66 |
| ROA Avg TTM | 4.89 |
| ROA Avg 3Y | 5.25 |
| Current VS TTM Avg | -4.70% |
| Current VS 3Y Avg | -11.32% |
| Current VS 5Y Avg | -13.86% |
ELV Return on Equity Metrics
| ROE | 12.90 |
| ROE Avg TTM | 13.69 |
| ROE Avg 3Y | 14.71 |
| Current VS TTM Avg | -5.74% |
| Current VS 3Y Avg | -12.33% |
| Current VS 5Y Avg | -13.58% |
ELV Net Profit Margin Metrics
| Net Profit Margin | 2.84% |
| Net Profit Margin Avg TTM | 3.11% |
| Net Profit Margin Avg 3Y | 3.37% |
| Current VS TTM Avg | -8.68% |
| Current VS 3Y Avg | -15.66% |
| Current VS 5Y Avg | -21.18% |
Last Updated: Tuesday, June 9, 2026
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux